Assessing vaccine safety communication with healthcare providers in a large urban county

Pharmacoepidemiol Drug Saf. 2012 Mar;21(3):269-75. doi: 10.1002/pds.2245. Epub 2011 Sep 29.

Abstract

Purpose: Vaccination is the primary public health tool for influenza control. Rapid assessment of the safety of any widely disseminated pandemic influenza vaccine is a public health priority. This study identifies practices, strengths, and weaknesses of vaccine-associated adverse event (AE) reporting to inform public health systems improvement.

Methods: A survey was developed with local and state health agencies' input. After pre-testing, the survey was distributed online and via mail to a random sample of King County, WA, healthcare professionals, composed of 60 commercial vaccinator employees and school health nurses, 500 physicians, and 300 pharmacists.

Results: The response rate was 36%. Results indicate that if an AE was suspected, 17% of respondents would not know how to report it, with 61% of respondents citing unclear definitions of a reportable AE as a barrier and 18% of respondents unaware of whose responsibility it is to report an AE.

Conclusion: Healthcare professionals who provide immunizations need additional information on their role in vaccine safety and AE reporting. Strengthening both passive and active reporting systems can enhance surveillance efforts during real-time events, such as mass immunization during a pandemic and other large-scale emergency countermeasure distribution programs.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adverse Drug Reaction Reporting Systems / standards*
  • Adverse Drug Reaction Reporting Systems / statistics & numerical data
  • Communication Barriers
  • Drug Hypersensitivity / epidemiology
  • Drug Hypersensitivity / etiology
  • Health Personnel / standards*
  • Health Personnel / statistics & numerical data
  • Humans
  • Pilot Projects
  • Surveys and Questionnaires
  • Urban Population* / statistics & numerical data
  • Vaccines / adverse effects*
  • Washington

Substances

  • Vaccines